Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Categories: diabetes

4/20/2018

Announcement advocating increased screenings for diabetes ignores harms of overdiagnosis

3 11/22/2016

Device for type 2 diabetes: Release prematurely touts benefits from 60-person study

11/10/2016

Weight Watchers for type 2 diabetes: PR release left out researchers’ many financial ties to the corporation

9/2/2016

Metformin ‘could slow development of heart disease’ in type 1 diabetes? Release vastly overstates what small study can tell us.

5/23/2016

PR release on oral insulin pill opened door to questions about benefits, evidence

2 3/25/2016

Exaggeration found in PR release claim that anyone can “reverse” their Type 2 diabetes

3/2/2016

Exemplary explanation of study comparing diabetic macular edema treatments

11/19/2015

Generally strong description of diabetic retinopathy drug trial — but more transparency please

5/1/2015

Does sleep apnea treatment really “lower diabetes risk”? This news release oversells the evidence

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
LizKayMendesElizabeth Kay Mendes@LizKayMendes·

“to project certainty where it simply does not exist is communication malpractice at a time like this and with a public health issue like this.” ⁦@garyschwitzer⁩ on ⁦@ContentScience⁩ https://review.content-science.com/covering-covid-19-vaccine-news-part-two-from-the-publisher-of-health-news-review/

Reply on Twitter 1291075113526464512Retweet on Twitter 12910751135264645123Like on Twitter 12910751135264645122Twitter 1291075113526464512
Retweet on TwitterHealthNewsReview.org Retweeted
ESchattnerElaine Schattner MD, MA@ESchattner·

In case you weren't aware: Prestigious journalism organizations and outlets take money from pharma, @garyschwitzer https://www.healthnewsreview.org/2020/08/drug-company-influence-on-journalism/#.XyrYGZeNvXA.twitter @HealthNewsRevu

Reply on Twitter 1291042197752745985Retweet on Twitter 12910421977527459851Like on Twitter 1291042197752745985Twitter 1291042197752745985
Retweet on TwitterHealthNewsReview.org Retweeted
WalshChildersKim Walsh-Childers@WalshChilders·

Addressing conflicts of interest ought to be a standard part of EVERY drug story. Journalism professors ought to be teaching students this, just as they teach them to include name, age and other standard story information. https://twitter.com/garyschwitzer/status/1290973141758611459

Reply on Twitter 1291042173929107464Retweet on Twitter 12910421739291074641Like on Twitter 12910421739291074644Twitter 1291042173929107464
View More

Categories

View More

Tags